Novavax expands Sanofi license for Matrix-M adjuvant use
Go back to Novavax expands Sanofi license for Matrix-M adjuvant use| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.13 -0.37 (3.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.50 | 52 Week High | $9.23 | |||
| Open | $9.68 | 52 Week Low | $1.16 | |||
| Day High | $9.99 | P/E | N/A | |||
| Day Low | $9.08 | EPS | $-0.30 | |||
| Volume | 9,458,295 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 42.38 -0.12 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.50 | 52 Week High | $44.76 | |||
| Open | $42.34 | 52 Week Low | $36.81 | |||
| Day High | $42.47 | P/E | N/A | |||
| Day Low | $41.86 | EPS | $0.00 | |||
| Volume | 4,085,505 | |||||
